No quarterly revenue total was found in AETHLON MEDICAL, INC.'s SEC filings.
Aethlon Medical, Inc. (AEMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$1.9 million. As of Jun 30, 2026 it held $4.9 million in cash and investments and $255,052 in total debt.
Revenue
—
Net income
$-1.55M
+12.1% vs year-ago quarter
Operating cash flow
$-1.90M
-10.6% vs year-ago quarter
Free cash flow
$-1.91M
-1.6% vs prior quarter
EPS
$-4.02
+90.5% vs year-ago quarter
Dividend per share
None
Shares outstanding
711,136
-72.6% vs year-ago quarter
Net cash
$4.68M
Q1 FY2027
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AEMD (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 882291
- Former names
- BISHOP EQUITIES INC (until Mar 13, 2000)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Jun 30, 2026 |
Q4 FY2026 Mar 31, 2026 |
Q3 FY2026 Dec 31, 2025 |
Q2 FY2026 Sep 30, 2025 |
Q1 FY2026 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$1.6M | -$1.9M | -$2.1M | -$1.5M | -$1.8M |
| Net income | -$1.5M | -$1.9M | -$2.0M | -$1.5M | -$1.8M |
| Diluted EPS | -$4.02 | -$1.48 | -$2.45 | -$3.74 | -$42.42 |
| Operating cash flow | -$1.9M | -$1.8M | -$1.9M | -$1.7M | -$1.7M |
| Free cash flow | -$1.9M | — | -$1.9M | — | — |
| Total assets | $6.2M | $6.3M | $8.1M | $7.3M | $5.3M |
| Total liabilities | — | $1.4M | $1.3M | $1.6M | $1.9M |
| Stockholders' equity | $5.2M | $4.9M | $6.7M | $5.7M | $3.4M |
| Cash and investments | $4.9M | $5.0M | $7.0M | $5.9M | $3.8M |
| Total debt | $255,052 | $336,718 | $417,522 | $496,772 | $573,852 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 9, 2026 | Oct 7, 2026 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Oct 5, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Material agreement, Change in control, Regulation FD disclosure
|
Sep 17, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 15, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Other events
|
Aug 31, 2026 | Aug 28, 2026 |
All 1000 Aethlon Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.